Skip to content

Total debt at other companies

ALN
Alnylam PharmaceuticalsALNY
$263.69M-4.5%
Septerna, Inc. logo
Septerna, Inc.SEPN
$23.09M-7.7%
Regenxbio logo
RegenxbioRGNX
$71.07M-11.0%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$823K-48.1%
Opko Health logo
Opko HealthOPK
$52.78M-4.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$410.7M-5.5%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Calculated from Tectonic Therapeutics’s reported figures.

Plus components not separately reported this period.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's total debt?
Tectonic Therapeutics (TECX) reported total debt of $4.9M in Q1 2026.
How has Tectonic Therapeutics's total debt changed year-over-year?
Tectonic Therapeutics's total debt increased by 86.1% year-over-year, from $2.63M to $4.9M.
What is the long-term trend for Tectonic Therapeutics's total debt?
Over 4 years (2021 to 2025), Tectonic Therapeutics's total debt has grown at a -44.1% compound annual growth rate (CAGR), from $16.54M to $1.62M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.